See original here: Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation
See original here: Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation
Continue reading here: Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™
Read the original: Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
Read more: Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
Continue reading here: Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
Visit link: Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
Read the original: Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance...
Go here to read the rest: argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
More: Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
Visit link: HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
Recent Comments